COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01710644
Recruitment Status : Completed
First Posted : October 19, 2012
Last Update Posted : June 7, 2016
Information provided by (Responsible Party):
Nordmark Arzneimittel GmbH & Co. KG

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2014
Actual Study Completion Date : August 2014
Certification/Extension First Submitted : April 4, 2016